Cantel Medical Corp. (NYSE:CMN) shares reached a new 52-week high during trading on Monday . The stock traded as high as $75.00 and last traded at $74.46, with a volume of 198,946 shares. The stock had previously closed at $72.03.

Several research analysts recently commented on CMN shares. Benchmark Co. started coverage on Cantel Medical Corp. in a research note on Monday. They set a “buy” rating and a $83.00 target price for the company. Needham & Company LLC initiated coverage on Cantel Medical Corp. in a research note on Wednesday, August 24th. They set a “hold” rating for the company.

The stock has a 50 day moving average price of $69.72 and a 200 day moving average price of $68.57. The firm has a market capitalization of $3.12 billion and a P/E ratio of 55.16.

Cantel Medical Corp. (NYSE:CMN) last issued its quarterly earnings results on Wednesday, June 8th. The company reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.08. The business had revenue of $173.70 million for the quarter, compared to analysts’ expectations of $163.16 million. The company’s revenue for the quarter was up 22.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.35 EPS. On average, analysts predict that Cantel Medical Corp. will post $1.43 earnings per share for the current fiscal year.

In related news, Director Mark N. Diker sold 7,000 shares of the stock in a transaction on Friday, June 10th. The stock was sold at an average price of $73.30, for a total value of $513,100.00. Following the transaction, the director now directly owns 439,872 shares of the company’s stock, valued at approximately $32,242,617.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Eric W. Nodiff sold 2,574 shares of the stock in a transaction on Friday, June 10th. The stock was sold at an average price of $72.97, for a total value of $187,824.78. Following the completion of the transaction, the executive vice president now directly owns 53,084 shares in the company, valued at $3,873,539.48. The disclosure for this sale can be found here.

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.